2-DG Anti-COVID Drug: DRDO explains how and when to use the medicine
Team Udayavani, Jun 1, 2021, 3:12 PM IST
DRDO’s new anti-Covid oral drug, 2-deoxy-D-glucose (2-DG), was recently granted emergency use approval by the Drug Controller General of India (DCGI) as an adjunct therapy in moderate cases of COVID-19.
The medicine was developed at the DRDO lab at the Institute of Nuclear Medicine and Allied Sciences (INMAS), New Delhi, in collaboration with Hyderabad-based pharma company Dr Reddy’s Laboratories (DRL).
The anti-COVID drug 2-DG has been developed in powder form and is ingested orally by dissolving it in water.
The DRDO said that 2-DG medicine should be used under the supervision of a doctor.
2-DG medicine should be prescribed early on by the doctors. It can be prescribed for up to 10 days and the recipients can be both moderate to severe COVID patients.
It is an adjunct therapy to go side-by-side with standard treatment of COVID-19 patients in hospital settings.
The drug should not be given to patients with uncontrolled diabetes, severe cardiac problem, ARDS, severe hepatic and renal impairment patients.
Also, Lactating and pregnant women and people below the age of 18 should not be prescribed with 2DG.
The DRDO also asked patients and attendants in need of the 2-DG drug to request the hospital to contact Dr Reddy’s Lab, Hyderabad for emergency medicine supply.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
AIADMK flays K’taka CM over Mekedatu, asks TN govt to safeguard farmers’ interest
Third wave in 6-8 weeks if Covid-appropriate behaviour not followed: AIIMS chief
WTC Final: Indian players wear black arm-bands in memory of Milkha Singh
Related Articles More
No proof of mock drill leading to death of 22 patients in Agra hospital: Report
Zydus Cadila likely to seek EUA for its COVID-19 vaccine next week
China and India Combat Coronavirus Pandemic Together: Online Ceremony Held for the Handover of Medical Supplies to Aid India
What is the role of animal serum in making of vaccines?
Children unlikely to get disproportionately hit by 3rd wave of COVID-19, reports study
Kuvempu University gets approval to conduct online courses
The admirer who broke Milkha’s record: Paramjit pays tribute to his role model
Bengal youth arrested for killing, buying four family members inside house
Youth Congress organises vaccine camps, distributes ration kits on Rahul Gandhi’s birthday
India Post to issue special cancellation stamp to mark International Yoga Day